Classical case of VITT after AZ vaccination from Canada. Instructive case report. Was the improvement in his condition due to the IVIG or the change form heparin to Fondaparinux? https://t.co/tBWECfSSgS #VITT https://t.co/dEzsf8k6vW
RT @UCalgaryMed: #UCalgaryMed’s Dr. Paul Petrasek, MD, co-writes in a new case study in @CMAJ with an important heads-up for the medical co…
#UCalgaryMed’s Dr. Paul Petrasek, MD, co-writes in a new case study in @CMAJ with an important heads-up for the medical community related to AstraZeneca vaccine and blood clots: https://t.co/59ycqWmeoX @LibinInstitute
Sospechar VIPIT ante trombopenia+trombosis+antecedente de vacunación -Detección anti FP/4 (con ELISA) otras técnicas dan falsos negativos -Anticoagular con fondaparinux, bivalirudina, argatroban o NACOs, NO con heparina -Inmonoglobulina iv -Transfusión de
RT @CMAJ: The case of a patient who developed VITT (vaccine-induced immune thrombotic thrombocytopenia) after receiving the AstraZeneca COV…
Here’s the related case presentation of #VITT
RT @CMAJ: The case of a patient who developed VITT (vaccine-induced immune thrombotic thrombocytopenia) after receiving the AstraZeneca COV…
RT @CMAJ: The case of a patient who developed VITT (vaccine-induced immune thrombotic thrombocytopenia) after receiving the AstraZeneca COV…
The case of a patient who developed VITT (vaccine-induced immune thrombotic thrombocytopenia) after receiving the AstraZeneca COVID-19 vaccine: https://t.co/ocrA7fEM4u VITT can present within 30 days of receiving an adenovirus vector COVID-19 vaccine.